343 related articles for article (PubMed ID: 30687735)
1. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis.
Kong W; Zuo X; Liang H; Hu J; Zhang H; Wang X; Chen W
Biomed Res Int; 2018; 2018():1723184. PubMed ID: 30687735
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and clinicopathological significance of glypican-3 overexpression in hepatocellular carcinoma: a meta-analysis.
Li J; Gao JZ; Du JL; Wei LX
World J Gastroenterol; 2014 May; 20(20):6336-44. PubMed ID: 24876756
[TBL] [Abstract][Full Text] [Related]
3. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
Zhou L; Zhu Y
Int J Surg; 2018 Aug; 56():274-280. PubMed ID: 29936198
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of pretreated serum lactate dehydrogenase level in nasopharyngeal carcinoma among Chinese population: A meta-analysis.
Zhang M; Wei S; Su L; Lv W; Hong J
Medicine (Baltimore); 2016 Aug; 95(35):e4494. PubMed ID: 27583859
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of alkaline phosphatase, gamma-glutamyl transpeptidase and lactate dehydrogenase in hepatocellular carcinoma patients treated with liver resection.
Wu SJ; Lin YX; Ye H; Xiong XZ; Li FY; Cheng NS
Int J Surg; 2016 Dec; 36(Pt A):143-151. PubMed ID: 27793641
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
7. The prognosis and clinicopathological significance of histone deacetylase in hepatocellular carcinoma: a meta-analysis.
Xue J; Ge P; Wu Y
Clin Exp Med; 2023 Sep; 23(5):1515-1536. PubMed ID: 36342581
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area.
Li MX; Zhao H; Bi XY; Li ZY; Yao XS; Li H; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Zhao DB; Cai JQ
Oncotarget; 2016 Dec; 7(52):86630-86647. PubMed ID: 27880930
[TBL] [Abstract][Full Text] [Related]
9. Baseline Albumin-Bilirubin grade as a predictor of response and outcome of regorafenib therapy in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
Xu H; Cao D; Zhou D; Zhao N; Tang X; Shelat VG; Samant H; Satapathy SK; Tustumi F; Aprile G; He A; Xu X; Ge W
BMC Cancer; 2023 Oct; 23(1):1006. PubMed ID: 37858207
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis.
Liu W; Hu K; Zhang F; Lu S; Chen R; Ren Z; Yin X
Int J Biol Markers; 2021 Jun; 36(2):17246008211032689. PubMed ID: 34374576
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Xiao WK; Chen D; Li SQ; Fu SJ; Peng BG; Liang LJ
BMC Cancer; 2014 Feb; 14():117. PubMed ID: 24559042
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging-based rim enhancement could effectually predict poor prognosis in hepatocellular carcinoma: a meta-analysis.
Lu Y; Cen Y; He X; Mo X; Luo F; Zhong Y
Eur J Gastroenterol Hepatol; 2024 May; 36(5):505-512. PubMed ID: 38555599
[TBL] [Abstract][Full Text] [Related]
13. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of hypoxia-inducible factors 1α and 2α in hepatocellular carcinoma: a systematic review with meta-analysis.
Méndez-Blanco C; Fernández-Palanca P; Fondevila F; González-Gallego J; Mauriz JL
Ther Adv Med Oncol; 2021; 13():1758835920987071. PubMed ID: 33613697
[TBL] [Abstract][Full Text] [Related]
15. The Prognostic Significance of NEK2 in Hepatocellular Carcinoma: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Cheng Y; Chen X; Ye L; Zhang Y; Liang J; Liu W; Zhou B; Zheng S; Huang Y; Chen G; Deng Y; Zhang Q; Yang Y
Cell Physiol Biochem; 2018; 51(6):2746-2759. PubMed ID: 30562736
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of platelet to lymphocyte ratio in hepatocellular carcinoma: a meta-analysis.
Ma W; Zhang P; Qi J; Gu L; Zang M; Yao H; Shi X; Wang C; Jiang Y
Sci Rep; 2016 Oct; 6():35378. PubMed ID: 27739490
[TBL] [Abstract][Full Text] [Related]
17. Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.
Xu XS; Qu K; Liu C; Zhang YL; Liu J; Song YZ; Zhang P; Liu SN; Chang HL
World J Gastroenterol; 2012 Dec; 18(48):7242-50. PubMed ID: 23326129
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis.
Wang Y; Peng C; Cheng Z; Wang X; Wu L; Li J; Huang C; Guo Q; Cai H
Int J Surg; 2018 Jul; 55():73-80. PubMed ID: 29787804
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
Fu SJ; Ji F; Han M; Chen MG; Wang XP; Ju WQ; Zhao Q; Wu LW; Ren QQ; Guo ZY; Wang DP; Zhu XF; Ma Y; He XS
Oncotarget; 2017 Jan; 8(3):4301-4312. PubMed ID: 27935864
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinicopathological significance of Gamma-Glutamyltransferase in patients with hepatocellular carcinoma: A PRISMA-compliant meta-analysis.
Sun P; Li Y; Chang L; Tian X
Medicine (Baltimore); 2019 May; 98(19):e15603. PubMed ID: 31083251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]